Mountain Valley MD Executes Soluvec™ 1% License Agreement, Expands Patent Protection
TORONTO, May 08, 2023 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB:MVMDF) (FRA: 20MP) is pleased to announce that Mountain Valley MD Inc. (“Mountain Valley”) has entered into a license agreement (the “Agreement”) with a privately held Ontario corporation (the “Licensee”) for its Soluvec™1% animal husbandry applications for the territory of the People’s Republic of Bangladesh.
Related news for (MVMDF)
- Mountain Valley MD Provides Business Update, Advances Commercialization
- Mountain Valley MD Announces Acquisition of Exclusive License for Agrarius, Launch of Performance Guarantee Program
- Mountain Valley MD Announces Stock Option Grant
- Mountain Valley MD Provides Business Update, Appoints New CFO
- Mountain Valley MD Announces Planned Appointment of New CFO Effective January 15, 2024